You're training smart, yet injuries keep derailing you. Here's why.

COL5A1 encodes collagen type V, which serves as a regulator of collagen fibril diameter in tendons and ligaments. It’s not the most abundant collagen type, but it’s critical: it determines how tightly organized your connective tissue fibers are and how strong they become under load. Think of it as the structural supervisor that ensures collagen molecules assemble into tight, resilient bundles.

The T allele at rs12722, present in roughly 30-35% of the population, is associated with higher injury risk in tendons and ligaments. People carrying this variant produce collagen fibers with slightly larger diameter and less optimal cross-linking. The result is connective tissue that looks normal but behaves as if it’s under greater stress even at moderate training loads. Your tendons and ligaments are mechanically weaker at the microscopic level.

This explains why you might tear or strain tissue doing movements that seem routine compared to what others handle. A sprint that feels controlled to you produces a hamstring strain. A catching movement in a sport causes an ankle sprain from an angle that shouldn’t normally cause one. Your connective tissue isn’t injured from poor technique or bad luck. It’s reaching its failure threshold sooner because the structural quality is lower.

COL1A1 produces collagen type I, the most abundant form of collagen in your body. It makes up roughly 90% of your bone matrix and is the primary structural protein in tendons. It’s the load-bearing scaffold that allows your skeleton and connective tissue to withstand mechanical stress.

Genetic variants in COL1A1 affect how densely and how strongly collagen type I fibers are organized. Some variants impair the cross-linking between collagen molecules, meaning the tissue looks structurally normal but has reduced stiffness and load capacity. Carriers of less favorable variants experience bone fragility and tendon weakness even without obvious symptoms until an injury occurs. Roughly 25-30% of people carry variants that reduce collagen I density or cross-linking efficiency.

For athletes, this manifests as stress fractures that seem to appear from nowhere, tendon pain that doesn’t clearly follow a training mistake, or a general sense that your bones and tendons fatigue faster than expected. You might have normal bone density on a DEXA scan but still experience stress fractures because the quality of the mineralized collagen matrix is suboptimal.

VDR is the vitamin D receptor, the protein that allows your cells to respond to vitamin D. Vitamin D doesn’t just regulate calcium. It’s a powerful signaling molecule that controls muscle protein synthesis, calcium handling during muscle contraction, and the inflammatory response to training stress. Your VDR is the lock; vitamin D is the key.

VDR variants, particularly FokI and BsmI polymorphisms present in 30-50% of people, reduce the receptor’s transcriptional activity. That means even if your vitamin D level is technically adequate (30-50 ng/mL), your cells are not responding as effectively to the vitamin D signal. You synthesize muscle protein more slowly after training, your muscles fatigue faster during intense work, and your recovery timeline extends beyond what your training plan accounts for. This becomes especially apparent during high-volume phases when muscle repair demand peaks.

You might notice that friends with similar vitamin D levels recover faster, build strength more quickly, or tolerate higher training volume without getting injured. The difference isn’t their training. It’s their cells’ ability to respond to the vitamin D they have.

SOD2, or superoxide dismutase 2, is your mitochondrial antioxidant. Every time you exercise, your mitochondria produce energy, and that process generates free radicals and oxidative byproducts. SOD2 neutralizes these compounds before they damage muscle tissue. It’s the cleanup crew that prevents training stress from turning into tissue damage.

The Val16Ala variant at rs4880, present in roughly 40% of people as the homozygous variant, reduces SOD2 enzyme activity. This means your mitochondria produce the same oxidative stress as everyone else’s during training, but you clear it more slowly. Oxidative damage accumulates in your muscle tissue, connective tissue, and mitochondria themselves, leading to higher muscle soreness (DOMS), slower recovery, and greater cumulative tissue damage over a training block. This damage is invisible to imaging and bloodwork, but it’s accumulating each session.

You might notice that you’re sore longer after hard sessions, your energy crashes harder the day after intense training, or you seem to develop overuse injuries faster despite the same training volume as others. That’s oxidative stress accumulating because your cleanup capacity is below average.

IL6 is interleukin-6, a signaling molecule that triggers and sustains inflammation. Some inflammation after training is necessary and beneficial. It signals your immune system to clear cellular debris and coordinate repair. But if your IL6 response is excessive or prolonged, that same inflammatory cascade damages tissue faster than it’s rebuilt.

IL6 promoter variants, particularly the -174G/C polymorphism, affect how readily your cells produce IL6 in response to training stress. People carrying the G allele tend to have higher baseline IL6 and more robust IL6 production after exercise. This creates a state of chronic low-level inflammation that accelerates tissue breakdown and suppresses repair efficiency. Roughly 40-50% of people carry alleles associated with elevated IL6 response. For athletes, this means your training stress is being amplified by an inflammatory response that’s working against you rather than with you.

You might notice that inflammation seems out of proportion to training stimulus: a single hard session leaves you sore and stiff for days, you seem to stay in a state of generalized muscle soreness even during lighter weeks, or joint pain and swelling show up even though training volume is controlled.

TNF, or tumor necrosis factor, is a potent inflammatory signaling molecule. Like IL6, some TNF activity is necessary for coordinating immune response and tissue repair. But excess TNF drives systemic inflammation that damages tissue faster than it can be rebuilt. TNF also suppresses muscle protein synthesis, directly impairing recovery.

TNF promoter variants, particularly -308G/A (rs1800629), affect baseline TNF production and TNF responsiveness to training stress. People carrying the A allele produce more TNF in response to physical stress. This creates a state where exercise triggers disproportionate systemic inflammation that suppresses recovery signaling and accelerates connective tissue breakdown. The A allele is present in roughly 20-30% of European populations. For athletes, elevated TNF means your body is literally inflaming itself in response to training, creating a net catabolic state even as you’re trying to build resilience.

You might experience generalized fatigue and brain fog after training sessions that should be recoverable, persistent low-grade fevers or malaise after hard efforts, or joint pain and swelling that doesn’t correlate with training volume or intensity.